Polyganics B.V.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Polyganics B.V. - overview
Established
1999
Location
Groningen, -, Netherlands
Primary Industry
Materials
About
Founded in 1999 and based in Groningen, Netherlands, Polyganics B. V. is a medical technology company that focuses on the development and manufacturing of bioresorbable medical devices. In 2022, the company was acquired by Collagen Matrix, Inc.
Rudy Mareel, CEO of the company, was previously CEO of Synthon and President of Cardinal Health International. The company's main products are bioresorbable medical devices. Bioresorbable medical devices promote natural tissue repair and regeneration based on polymer platforms. Its products are used in ENT surgery, peripheral nerve repair, general surgery and neurosurgery, etc.
Current Investors
Regenity Biosciences
Primary Industry
Materials
Sub Industries
Medical Devices & Equipment, Biopolymer Materials
Website
www.polyganics.com
Verticals
Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Polyganics B.V. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Polyganics B.V. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.